[Health economics in hepatology: who should pay? Is expensive treatment in hepatology cost effective?].
Rossol
S
S
I Medizinische Klinik, Klinikum Rüsselsheim. siegbertrossol@web.de
D000998:Antiviral Agents / Q000191:economics / Q000627:therapeutic use; D002908:Chronic Disease; D003362:Cost-Benefit Analysis; D018450:Disease Progression; D004359:Drug Therapy, Combination; D005858:Germany; D017048:Health Care Costs; D006525:Hepatitis, Viral, Human / Q000188:drug therapy* / Q000191:economics* / Q000401:mortality; D006801:Humans; D008017:Life Expectancy; D011788:Quality of Life; D016896:Treatment Outcome
D000998:Antiviral Agents